Status:

COMPLETED

Professional Continuous Glucose Monitoring as an Adjuvant Educational Tool for Improving Glycemic Control in Patients With Type 2 Diabetes.

Lead Sponsor:

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Collaborating Sponsors:

Medtronic, PLC

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

The investigators conducted a three-month quasi-experimental study with an intervention and control group and ex-ante and ex-post evaluations in one family medicine clinic in Mexico City. Participants...

Detailed Description

From May to October 2017, the investigators conducted a three-month pilot study with intervention and control groups and ex-ante and ex-post evaluations in one ISSSTE family medicine clinic in Mexico ...

Eligibility Criteria

Inclusion

  • Patients with type 2 diabetes with HbA1c\>8 mg/dL, without diagnosis of a memory disorder who agreed to participate and signed an informed consent form

Exclusion

  • None

Key Trial Info

Start Date :

May 30 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2017

Estimated Enrollment :

302 Patients enrolled

Trial Details

Trial ID

NCT04667728

Start Date

May 30 2017

End Date

October 30 2017

Last Update

December 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clínica de Medicina Familiar Oriente

México, Mexico, 09220

Professional Continuous Glucose Monitoring as an Adjuvant Educational Tool for Improving Glycemic Control in Patients With Type 2 Diabetes. | DecenTrialz